Fortrea Holdings, Inc. (FTRE)
20.00
+0.60
(+3.09%)
USD |
NASDAQ |
Oct 02, 16:00
20.00
0.00 (0.00%)
After-Hours: 20:00
Fortrea Holdings Enterprise Value : 2.851B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.851B |
| October 01, 2026 | 2.794B |
| September 30, 2026 | 2.846B |
| September 29, 2026 | 2.826B |
| September 28, 2026 | 2.857B |
| September 25, 2026 | 2.840B |
| September 24, 2026 | 2.853B |
| September 23, 2026 | 2.805B |
| September 22, 2026 | 2.892B |
| September 21, 2026 | 2.853B |
| September 18, 2026 | 2.844B |
| September 17, 2026 | 2.878B |
| September 16, 2026 | 2.848B |
| September 15, 2026 | 2.825B |
| September 14, 2026 | 2.605B |
| September 11, 2026 | 2.585B |
| September 10, 2026 | 2.568B |
| September 09, 2026 | 2.546B |
| September 08, 2026 | 2.571B |
| September 04, 2026 | 2.632B |
| September 03, 2026 | 2.720B |
| September 02, 2026 | 2.695B |
| September 01, 2026 | 2.634B |
| August 31, 2026 | 2.696B |
| August 28, 2026 | 2.738B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.742B |
| August 26, 2026 | 2.711B |
| August 25, 2026 | 2.686B |
| August 24, 2026 | 2.690B |
| August 21, 2026 | 2.698B |
| August 20, 2026 | 2.679B |
| August 19, 2026 | 2.674B |
| August 18, 2026 | 2.623B |
| August 17, 2026 | 2.670B |
| August 14, 2026 | 2.605B |
| August 13, 2026 | 2.644B |
| August 12, 2026 | 2.692B |
| August 11, 2026 | 2.805B |
| August 10, 2026 | 2.755B |
| August 07, 2026 | 2.702B |
| August 06, 2026 | 2.631B |
| August 05, 2026 | 2.761B |
| August 04, 2026 | 2.660B |
| August 03, 2026 | 2.750B |
| July 31, 2026 | 2.772B |
| July 30, 2026 | 2.763B |
| July 29, 2026 | 2.889B |
| July 28, 2026 | 2.917B |
| July 27, 2026 | 2.775B |
| July 24, 2026 | 2.805B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Charles River Laboratories International, Inc. | 16.72B |
| IQVIA Holdings, Inc. | 56.79B |
| Medpace Holdings, Inc. | 16.33B |
| Champions Oncology, Inc. | 75.94M |
| Avantor, Inc. | 13.77B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.20M |
| Revenue (Quarterly) | 678.20M |
| Total Expenses (Quarterly) | 691.40M |
| EPS Diluted (Quarterly) | -0.1392 |
| Gross Profit Margin (Quarterly) | 17.63% |
| Profit Margin (Quarterly) | -1.95% |
| Earnings Yield | -4.58% |
| Operating Earnings Yield | 1.39% |
| Normalized Earnings Yield | -3.168 |